Nippon Indosari Corpindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Nippon Indosari Corpindo Tbk. trades at Rp610 (market cap 3.77T, 333.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.1× Nippon Indosari Corpindo Tbk.'s market cap, and Nippon Indosari Corpindo Tbk. is more actively traded (333.9K versus 278.4K). Which is the better fit depends on your goals.
| ROTI | TSPC | |
|---|---|---|
Market Cap | 3.77T | 11.64T |
Volume | 333.9K | 278.4K |
Lot | 3.34K | 2.78K |
Turnover | 202.85M | 723.93M |
Average Price | 607.52 | 2,600.31 |
Value | 202.85M | 723.93M |
Indicative Equilibrium Price | 610 | 2,610 |
Indicative Equilibrium Volume | 81 | 74 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →